ATYR
aTyr Pharma, Inc.
0.3752$
+5.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | -100.0% | – | – | – | – | – | -100.0% | – | – | – | |
| – | -59.0% | +89.2% | -50.3% | +1.3% | +3,051.5% | -96.9% | +1.0% | +5,618.3% | -98.2% | +0.0% | – | – | |
| – | – | – | -263.0% | – | – | – | – | – | – | – | – | – | |
| – | +23.6% | +4.8% | +4.6% | +6.0% | -17.4% | -3.4% | +30.2% | +43.9% | -50.8% | -32.8% | -7.8% | – | |
| – | +21.0% | +9.5% | -4.7% | -0.2% | +7.7% | +10.2% | +24.5% | -2.5% | -18.7% | +5.5% | +0.3% | – | |
| – | +29.9% | +8.5% | +2.6% | +4.8% | -80.2% | +339.1% | +28.8% | -76.3% | +207.9% | -25.4% | -1.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.